News
16h
HealthDay on MSNGuidelines Developed to Improve Newborn Screening for Cystic FibrosisIn a guideline issued by the U.S. Cystic Fibrosis Foundation and published online April 2 in the International Journal of ...
MONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those from other racial and ethnic backgrounds, researchers report. Cystic ...
18h
Verywell Health on MSNWhat Is Pancreas Divisum? Causes, Diagnosis, and TreatmentPancreas divisum is a congenital condition affecting drainage. Learn its causes, symptoms, diagnosis, and treatment options, ...
Dr. Greg Shay, a retired Catholic doctor, spent a month in Gaza in the fall. Back in the U.S., he wishes Catholics would be ...
A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.
A 47-year-old man with cystic fibrosis hopes that stories like his will be reassuring to younger people diagnosed with the ...
4d
HealthDay on MSNCystic Fibrosis Screening Favors White Children, Report SaysMONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results